Research for the Molecular Imaging of the HER2 Targeting Tracer
Clinical trial NCT04547309 · RECRUITING
Trial details
- NCT number
- NCT04547309
- Sponsor
- Peking University Cancer Hospital & Institute
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-07
- Primary completion
- 2026-08-30
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.